Clinical trial
Infusion of Donor Lymphocytes Transduced With the Suicide Gene HSV TK in…
NCT00423124 · AGC Biologics S.p.A., Industry · Completed
Key facts
| NCT number | NCT00423124 |
|---|---|
| Title | Infusion of Donor Lymphocytes Transduced With the Suicide Gene HSV TK in Patients With Haematological Malignancies |
| Official title | A Phase I-II Study: Infusion of Donor Lymphocytes Transduced With the Suicide Gene HSV TK, After Transplantation of Allogeneic T-depleted Stem Cells From a Haploidentical Donor in Patients With Haematological Malignancies |
| Lead sponsor | AGC Biologics S.p.A., Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Hematological Malignancies |
| Intervention type | Genetic |
| Interventions | HSV-TK |
| Enrollment | 57 |
| Start date | Jul 1, 2002 |
| Primary completion | Dec 1, 2011 |
| Completion | Nov 1, 2013 |
| First posted | Jan 17, 2007 |
| Last update posted | May 30, 2014 |
| Countries | Germany, Greece, Israel, Italy, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: